Public company info - New Horizon Health Limited - B , 06606.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

New Horizon Health Limited - B, 06606.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12
Net Cash Flow from Operating Activities -412,760 -354,594 -131,769 -74,988 -55,826
Net Cash Flow from Return on Investments & Servicing of Finance 8,730 5,031 -4,571 690 1,097
　Interest Received 13,067 13,226 2,294 1,843 1,555
　Interest Paid -4,337 -8,195 -6,865 -1,153 -458
　Dividend Received 0 0 0 0 0
　Dividend Paid 0 0 0 0 0
　Others 0 0 0 0 0
Taxes (Paid) / Refunded 222 0 -533 0 0
Net Cash Flow from Investing Activities 678,893 -1,200,535 -171,941 -37,854 -18,289
　Additions to Fixed Assets -47,472 -35,354 -20,825 -22,908 -11,471
　Disposal of Fixed Assets 6 14 129 0 57
　Increase in Investments -29,925 -65,777 0 0 0
　Decrease in Investments 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 22,069 6 5
　Others 756,284 -1,099,418 -173,314 -14,952 -6,880
Net Cash Flow before Financing Activities 275,085 -1,550,098 -308,814 -112,152 -73,018
Net Cash Flow from Financing Activities 79,815 1,792,016 439,300 376,969 -5,746
　New Loans 180,000 0 70,000 55,500 0
　Loans Repayment -101,392 -51,544 -14,062 -13,412 -5,751
　Fixed Income/Debt Instruments 0 0 363,524 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0
　Equity Financing 1,207 1,843,560 540 524,469 0
　Net Cash Flow with Related Parties 0 0 22,069 6 5
　Others 0 0 -2,771 -189,594 0
Increase(Decrease) in Cash & Cash Equivalents 354,900 241,918 130,486 264,817 -78,764
Cash & Cash Equivalents at Beginning of Year 686,817 451,796 346,434 76,691 155,330
Net Cash Flow due to Change in Exchange Rate/Others 89,656 -6,897 -25,124 4,926 125
Cash & Cash Equivalents at End of Year 1,131,373 686,817 451,796 346,434 76,691
Currency Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2025
Suntek Computer Systems Limited.
All rights reserved